Kite Pharma is a publicly traded, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T-cell therapy (CARs and TCRs), designed to restore the immune system’s ability to recognize and eradicate tumors.

biopharmaceuticals
Public (NASDAQ: KITE)
Visit Website
Additional Portfolio Companies
Adicet Bio
ArQule
BioBlast Pharma
Cathworks
cCAM Biotherapeutics
CheckCap
Eloxx Pharmaceuticals
Enlivex Therapeutics
Entera Bio
Eyevensys
EyeYon
ForSight Vision6 (“V6”)
Hairstetics
Headsense
Horama
Keros Therapeutics
Kite Pharma
LogicBio Therapeutics
Metabomed
NovellusDX
Novus Therapeutics
Ocon Medical
PACT Pharma
Pi Therapeutics
Protalix
Raziel Therapeutics
ReWalk
VBI Vaccines
Step Pharma
StimatixGI
Sweetch
TargEDys
UroGen
V-Wave
July 12, 2015